NASDAQ NMS - GLOBAL MARKET · HOWL

+3.11% · +$0.0112 · Vol 592.3K

Market closed · last close 4:00 PM ET · price as of 19:33:02 ET

Werewolf Therapeutics Inc

Biotechnology

$0.3710

+ Add to watchlist

Card

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is HOWL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move HOWL next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Form 4 / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 9
Score
Score moved -5
58/NEUTRAL -> 53/NEUTRAL
Veridion score historySource
Jun 22
Form 4Sovereign
RA Capital Healthcare Fund LP Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 16
Form 4Sovereign
RA Capital Healthcare Fund LP Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 11
Form 4Sovereign
RA Capital Healthcare Fund LP Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 10
Form 4Sovereign
EVNIN LUKE Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 8
Form 4Sovereign
EVNIN LUKE Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
Jun 3
Form 4Sovereign
EVNIN LUKE Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 29
Form 4Sovereign
EVNIN LUKE Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt
May 26
Form 4Sovereign
EVNIN LUKE Form 4 sale
Disclosure detail is available inside Sovereign and Reserve.
SEC Form 4Unlock receipt

Catalyst calendar

Dated receipts for HOWL are being assembled.

About Werewolf Therapeutics Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2021

Employees

Country

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$0.3600

Day high

$0.3849

Day low

$0.3521

Previous close

$0.3598

52W high

$0.3849

-3.61% from high

52W low

$0.3521

58% of range

Market cap

$17.5M

EPS

$-1.4400

Shares out

48.6M

Volume

592.3K

VWAP

$0.3701

Price history computed in-house

SMA 50 $0.3710 · above

SMA 200 $0.3710 · above

52W position 58%

Veridion warehouse edge

Warehouse intelligence for HOWL.

Veridion Score

0: 891: 652: 183: Not reported4: Not reported5: Not reported

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

HOWL insider activity

Werewolf Therapeutics Inc

Score

Coverage building

Pressure

Net selling

Filings

160

Buys / sells

0 / 160

Net value

-$8.6M

Insiders

Named filers

RA Capital Healthcare Fund LP

Insider

Leadership

EVNIN LUKE

Insider

Leadership

MPM BioVentures 2014, L.P.

Insider

Leadership

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$8.6M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-06-22	2026-06-17	RA Capital Healthcare Fund LP	Insider	sell	$0.35	27,695	303,719	$10K	SEC Form 4
2026-06-22	2026-06-17	RA Capital Healthcare Fund LP	Insider	sell	$0.35	389,216	4,268,448	$136K	SEC Form 4
2026-06-16	2026-06-16	RA Capital Healthcare Fund LP	Insider	sell	$0.37	9,939	331,414	$4K	SEC Form 4
2026-06-16	2026-06-16	RA Capital Healthcare Fund LP	Insider	sell	$0.37	139,686	4,657,664	$52K	SEC Form 4
2026-06-16	2026-06-15	RA Capital Healthcare Fund LP	Insider	sell	$0.39	8,554	341,353	$3K	SEC Form 4